Business Description
Patrys Ltd
SIC : 2836
ISIN : AU000000PAB9
Description
Patrys Ltd focuses on the development of natural human antibody-based therapies for the treatment of cancer. The company's product includes Deoxymab 3E10, PAT-SC1, PAT-DX1 PAT-DX1-NP, PAT-DX3, and PAT-LM1. Its main technology is Deoxymab 3E10, a DNA damage repair (DDR) antibody that penetrates live cell nuclei and inhibits key mechanisms of DNA repair in target cancer cells.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.9 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -18.6 | |||||
3-Year FCF Growth Rate | -14.5 | |||||
3-Year Book Growth Rate | -15.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 8.95 | |||||
Quick Ratio | 8.95 | |||||
Cash Ratio | 7.64 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -23.8 | |||||
Shareholder Yield % | -0.03 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -70.86 | |||||
ROA % | -62.31 | |||||
ROIC % | -251.93 | |||||
ROC (Joel Greenblatt) % | -333.95 | |||||
ROCE % | -94.96 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 3.5 | |||||
EV-to-EBIT | -1.45 | |||||
EV-to-EBITDA | -1.45 | |||||
EV-to-FCF | -7.15 | |||||
Earnings Yield (Greenblatt) % | -68.97 | |||||
FCF Yield % | -9.65 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PATLF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Patrys Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.002 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0 | ||
20-Day SMA ($) | 0.04 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 0.04 - 0.04 | ||
Shares Outstanding (Mil) | 2,057.45 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Patrys Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Patrys Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Patrys Ltd Frequently Asked Questions
What is Patrys Ltd(PATLF)'s stock price today?
The current price of PATLF is $0.04. The 52 week high of PATLF is $0.04 and 52 week low is $0.04.
When is next earnings date of Patrys Ltd(PATLF)?
The next earnings date of Patrys Ltd(PATLF) is .
Does Patrys Ltd(PATLF) pay dividends? If so, how much?
Patrys Ltd(PATLF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |